BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23269260)

  • 21. Treatment and prognosis of limited disease primary small cell carcinoma of esophagus.
    Chen SB; Yang JS; Yang WP; Weng HR; Li H; Liu DT; Chen YP
    Dis Esophagus; 2011 Feb; 24(2):114-9. PubMed ID: 21040151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II study of concurrent chemoradiotherapy at the dose of 50.4 Gy with elective nodal irradiation for Stage II-III esophageal carcinoma.
    Kato K; Nakajima TE; Ito Y; Katada C; Ishiyama H; Tokunaga SY; Tanaka M; Hironaka S; Hashimoto T; Ura T; Kodaira T; Yoshimura K
    Jpn J Clin Oncol; 2013 Jun; 43(6):608-15. PubMed ID: 23585687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Semi-radical chemoradiotherapy for 53 esophageal squamous cell carcinomas with supraclavicular lymph node metastasis in a single institutional retrospective study.
    Yamashita M; Takenaka HY; Nakagawa K
    Hepatogastroenterology; 2014 Oct; 61(135):1971-8. PubMed ID: 25713897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A patient with stage IVb small cell carcinoma of the esophagus who survived 23 months after systemic cancer chemotherapy].
    Tsujie M; Shibata N; Nomura T; Tanaka T; Morimoto T; Fujita S; Kitani K; Nakahira S; Okuda H; Takeda M
    Gan To Kagaku Ryoho; 2003 Feb; 30(2):271-5. PubMed ID: 12610878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small cell carcinoma of the esophagus. Analysis of 14 cases and literature review.
    Hosokawa A; Shimada Y; Matsumura Y; Yamada Y; Muro K; Hamaguchi T; Igaki H; Tachimori Y; Kato H; Shirao K
    Hepatogastroenterology; 2005; 52(66):1738-41. PubMed ID: 16334769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. KIT and PDGFRA in esophageal pure small cell carcinoma.
    Terada T
    Int J Clin Exp Pathol; 2011; 4(7):718-21. PubMed ID: 22076173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A case report of esophageal small cell carcinoma responding well to chemotherapy of 5-FU and cisplatin combined with radiotherapy].
    Yoshikawa T; Kato H; Nikkuni K; Sasaki K; Tomidokoro T; Satoh T
    Gan To Kagaku Ryoho; 1999 Jul; 26(8):1181-4. PubMed ID: 10431586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II feasibility study of preoperative concurrent chemoradiotherapy with cisplatin plus 5-fluorouracil and elective lymph node irradiation for clinical stage II/III esophageal squamous cell carcinoma.
    Hashimoto J; Kato K; Ito Y; Kojima T; Akimoto T; Daiko H; Hamamoto Y; Matsushita H; Katano S; Hara H; Tanaka Y; Saito Y; Nagashima K; Igaki H
    Int J Clin Oncol; 2019 Jan; 24(1):60-67. PubMed ID: 30109544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary small cell neuroendocrine carcinoma of the tonsil: a case report and review of the literature.
    Wang HY; Zou J; Zhou GY; Yan JQ; Liu SX
    Int J Clin Exp Pathol; 2014; 7(5):2678-82. PubMed ID: 24966986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Small cell carcinoma of the esophagus: a multicentre Rare Cancer Network study.
    Vos B; Rozema T; Miller RC; Hendlisz A; Van Laethem JL; Khanfir K; Weber DC; El Nakadi I; Van Houtte P
    Dis Esophagus; 2011 May; 24(4):258-64. PubMed ID: 21073624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Esophageal carcinosarcoma treated with surgery and chemoradiotherapy-a report of 4 cases].
    Takemoto K; Shiozaki A; Fujiwara H; Shimizu H; Konishi H; Komatsu S; Kubota T; Ichikawa D; Okamoto K; Morimura R; Murayama Y; Ikoma H; Kuriu Y; Nakanishi M; Sakakura C; Otsuji E
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2106-8. PubMed ID: 24394028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Multivariate prognostic analysis for patients with unresectable esophageal carcinoma after concurrent chemoradiotherapy].
    Chen EC; Liu MZ; Hu YH; Li QQ; Liu H; Cai L; Liu H; Lin HX; Huang Y; Wang HY; Cui NJ
    Ai Zheng; 2005 Jun; 24(6):731-4. PubMed ID: 15946490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A single institutional non-randomized retrospective comparison between definitive chemoradiotherapy and radical surgery in 82 Japanese patients with resectable esophageal squamous cell carcinoma.
    Yamashita H; Nakagawa K; Yamada K; Kaminishi M; Mafune K; Ohtomo K
    Dis Esophagus; 2008; 21(5):430-6. PubMed ID: 19125797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison between radical esophagectomy and definitive chemoradiotherapy in patients with clinical T1bN0M0 esophageal cancer.
    Motoori M; Yano M; Ishihara R; Yamamoto S; Kawaguchi Y; Tanaka K; Kishi K; Miyashiro I; Fujiwara Y; Shingai T; Noura S; Ohue M; Ohigashi H; Nakamura S; Ishikawa O
    Ann Surg Oncol; 2012 Jul; 19(7):2135-41. PubMed ID: 22302264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Salvage Surgery after CRT for Advanced Esophageal Cancer Resulting in a Pathological Complete Response and More Than Five Years' Survival].
    Kaida S; Murata S; Yamaguchi T; Ohtake R; Takebayashi K; Yamamoto H; Ueki T; Miyake T; Iida H; Akabori H; Sonoda H; Mori T; Shimizu T; Naka S; Tani M
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):2007-2009. PubMed ID: 28133204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A case of stage IVb small cell carcinoma of the esophagus obtained prolonged survival after combined modality therapy].
    Mizuuchi Y; Anbe K; Yamagata N; Ohji Y; Kanamoto K; Yao T
    Gan To Kagaku Ryoho; 2010 Apr; 37(4):715-8. PubMed ID: 20414033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Etoposide and cisplatin versus irinotecan and cisplatin in patients with limited-stage small-cell lung cancer treated with etoposide and cisplatin plus concurrent accelerated hyperfractionated thoracic radiotherapy (JCOG0202): a randomised phase 3 study.
    Kubota K; Hida T; Ishikura S; Mizusawa J; Nishio M; Kawahara M; Yokoyama A; Imamura F; Takeda K; Negoro S; Harada M; Okamoto H; Yamamoto N; Shinkai T; Sakai H; Matsui K; Nakagawa K; Shibata T; Saijo N; Tamura T;
    Lancet Oncol; 2014 Jan; 15(1):106-13. PubMed ID: 24309370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical tools do not predict pathological complete response in patients with esophageal squamous cell cancer treated with definitive chemoradiotherapy.
    Molena D; Sun HH; Badr AS; Mungo B; Sarkaria IS; Adusumilli PS; Bains MS; Rusch VW; Ilson DH; Rizk NP
    Dis Esophagus; 2014; 27(4):355-9. PubMed ID: 24033404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A case of superficial small cell carcinoma of the esophagus].
    Hirota M; Nakamura E; Yamashita K; Ichihara T
    Gan To Kagaku Ryoho; 2009 Sep; 36(9):1537-9. PubMed ID: 19755828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective, multicenter phase I/II study of induction chemotherapy with docetaxel, cisplatin and fluorouracil (DCF) followed by chemoradiotherapy in patients with unresectable locally advanced esophageal carcinoma.
    Satake H; Tahara M; Mochizuki S; Kato K; Hara H; Yokota T; Kiyota N; Kii T; Chin K; Zenda S; Kojima T; Bando H; Yamazaki T; Iwasa S; Honma Y; Hamauchi S; Tsushima T; Ohtsu A
    Cancer Chemother Pharmacol; 2016 Jul; 78(1):91-9. PubMed ID: 27193097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.